Octapharma Research Site

Boston, Massachusetts 02215

1 studies enrolling now · 3 studies all time

What they study most

Pediatric Acute-Onset Neuropsychiatric Syndrome, Significant Bleeding Risk, Vitamin K-Dependent Coagulation Defect

Studies at this site

• Post Marketing Observational Study on Safety of BALFAXAR vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in Adults Undergoing Urgent Surgery or Invasive Procedure — Recruiting now
• Phase III Study To Compare The Effect of Panzyga Versus Placebo in Patients With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS/PANDAS) — Completed
• Study of Octaplex, a Four-factor Prothrombin Complex Concentrate (4F-PCC) and Beriplex® P/N (Kcentra) for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk. — Completed